Bausch Health Companies publie ses résultats sur une base trimestrielle. Ces rapports trimestriels sur les résultats donnent aux investisseurs un aperçu des résultats financiers d'une entreprise sur une période de 3 mois. Les rapports sur les résultats incluent presque toujours les résultats du BPA et du chiffre d'affaires.
Analysez l'historique des bénéfices de Bausch Health Companies en utilisant des tris et des filtres avancés.
Get Alert  | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
BHC  | Bausch Health Companies  | $1.12  | $1.06  | $1.16  | 9.43%  | $2.51B  | $2.62B  | $2.68B  | 2.51%  | 10/29/2025  | |
BHC  | Bausch Health Companies  | $0.98  | $0.95  | $0.91  | -4.21%  | $2.40B  | $2.48B  | $2.53B  | 2.21%  | 07/30/2025  | |
BHC  | Bausch Health Companies  | $0.59  | $0.85  | $0.61  | -28.24%  | $2.15B  | $2.29B  | $2.26B  | -1.35%  | 04/30/2025  | |
BHC  | Bausch Health Companies  | $1.15  | $1.19  | $1.17  | -1.68%  | $2.41B  | $2.52B  | $2.56B  | 1.39%  | 02/19/2025  | |
BHC  | Bausch Health Companies  | $1.03  | $1.02  | $1.12  | 9.80%  | $2.24B  | $2.42B  | $2.51B  | 3.72%  | 10/30/2024  | |
BHC  | Bausch Health Companies  | $0.81  | $0.88  | $0.98  | 11.36%  | $2.17B  | $2.34B  | $2.40B  | 2.69%  | 08/01/2024  | |
BHC  | Bausch Health Companies  | $0.52  | $0.72  | $0.59  | -18.06%  | $1.94B  | $2.16B  | $2.15B  | -0.32%  | 05/02/2024  | |
BHC  | Bausch Health Companies  | $1.03  | $1.02  | $1.15  | 12.75%  | $2.19B  | $2.30B  | $2.41B  | 4.70%  | 02/22/2024  | |
BHC  | Bausch Health Companies  | $0.76  | $0.90  | $1.03  | 14.44%  | $2.05B  | $2.15B  | $2.24B  | 4.04%  | 11/02/2023  | |
BHC  | Bausch Health Companies  | $0.55  | $0.75  | $0.81  | 8.00%  | $1.97B  | $2.04B  | $2.17B  | 6.23%  | 08/03/2023  | |
BHC  | Bausch Health Companies  | $0.72  | $0.72  | $0.52  | -27.78%  | $1.92B  | $1.97B  | $1.94B  | -1.32%  | 05/04/2023  | |
BHC  | Bausch Health Companies  | $0.19  | $0.91  | $1.03  | 13.19%  | $2.20B  | $2.14B  | $2.19B  | 2.48%  | 02/23/2023  | |
BHC  | Bausch Health Companies  | $0.52  | $1.26  | $0.76  | -39.68%  | $2.11B  | $2.80B  | $2.05B  | -26.93%  | 11/03/2022  | |
BHC  | Bausch Health Companies  | $0.97  | $1.15  | $0.55  | -52.17%  | $2.10B  | $2.61B  | $1.97B  | -24.64%  | 08/09/2022  | |
BHC  | Bausch Health Companies  | $1.02  | $1.28  | $0.72  | -43.75%  | $2.03B  | —  | $1.92B  | —  | 05/10/2022  | |
BHC  | Bausch Health Companies  | $1.33  | $1.42  | $1.27  | -10.56%  | $2.21B  | $2.80B  | $2.20B  | -21.57%  | 02/23/2022  | |
BHC  | Bausch Health Companies  | $1.32  | $1.29  | $1.15  | -10.85%  | $2.14B  | $2.66B  | $2.11B  | -20.64%  | 11/02/2021  | |
BHC  | Bausch Health Companies  | $0.46  | $0.95  | $0.97  | 2.11%  | $1.66B  | $2.12B  | $2.10B  | -0.94%  | 08/03/2021  | |
BHC  | Bausch Health Companies  | $0.88  | $0.96  | $1.02  | 6.25%  | $2.01B  | $2.06B  | $2.03B  | -1.60%  | 05/04/2021  | |
BHC  | Bausch Health Companies  | $1.12  | $1.12  | $1.33  | 18.75%  | $2.22B  | $2.17B  | $2.21B  | 1.98%  | 02/24/2021  | 
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % | 
|---|---|---|---|---|
| Q3 | 2025-10-29 | $1.16 | $1.06 | 9.43 % | 
| Q2 | 2025-07-30 | $0.91 | $0.95 | -4.21 % | 
| Q1 | 2025-04-30 | $0.61 | $0.85 | -28.2 % | 
| Q4 | 2025-02-19 | $1.17 | $1.19 | -1.68 % | 
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % | 
|---|---|---|---|---|
| Q3 | 2025-10-29 | $2.68B | $2.62B | 2.51 % | 
| Q2 | 2025-07-30 | $2.53B | $2.48B | 2.21 % | 
| Q1 | 2025-04-30 | $2.26B | $2.29B | -1.35 % | 
| Q4 | 2025-02-19 | $2.56B | $2.52B | 1.39 % | 
Bausch Health Companies (BHC) n'a pas de rapports de bénéfices à venir prévus. Les derniers bénéfices rapportés étaient pour Q3 le octobre 29, 2025.
Bausch Health Companies (BHC) n'a pas de rapports de bénéfices à venir prévus. Les derniers bénéfices rapportés étaient pour Q3 le octobre 29, 2025 et le BPA réel était de $1.16, ce qui dépassé l'estimation de $1.06.
Bausch Health Companies (BHC) n'a pas de rapports de bénéfices à venir prévus. Les derniers bénéfices rapportés étaient pour Q3 le octobre 29, 2025 et le chiffre d'affaires réel était de $2.7B, ce qui dépassé l'estimation de $2.6B.
Parcourir estimations des bénéfices, EPS et chiffre d'affaires sur toutes les actions.